Professor Simon Heller provides guidance to initiating basal insulin and managing hypoglycaemia.Learning objective: Following this activity you will be able to confidently initiate basal insulin

P Professor Chan discusses SU-related hypoglycaemia and provides practical advice for its management.Learning objective: Following this activity, you will be able to better reduce risk of SU-induced hypoglycaemia and support patients in managing it.

Professor Michael Vallis and Joe Dias discuss how to identify and use teachable moments to help people with diabetes achieve glycaemic control earlier.Learning objective: Following this activity, you will be more confident in motivating patients to change their behaviour

Professor Knop outlines why treating early and intensifying treatment as appropriate is likely to reduce diabetes-related complications. Learning objectives: Following this activity, you will be able to better discuss the link between loss of beta cell function, glycaemic control and risk of complications. Better recognize when treatment intensification should be considered

Mr Joe Dias discusses how continuous glucose monitoring can transform lives.Learning objective: Following this activity, you will be more confidently discuss the benefits of continuous glucose monitoring with people with diabetes.

Listen to Professor Liebl outline when and how he uses these modern agents.Learning objective: Following this activity, you will be able to confidently identify individuals in whom SGLT-2 inhibitors and GLP-1 receptor agonists are likely to be the preferred therapeutic option after metformin.

Clinical practice in type 2 diabetes has changed, learn more from Professor Abrahamson.Learning objective: Following this activity, you will be able to more confidently tailor treatments for people with T2DM, particularly newer agents

Professor Liebl discusses best communication approaches for insulins and GLP-1 RAs. Learning objective: Following this activity, you will be able to better overcome the barriers to initiating injectables and discuss the differences between insulins and GLP-1 RAs.

Professor Kamlesh Khunti discusses what the key characteristics of therapeutic agents available in diabetes are.Learning objective: Following this activity, you will be able to adopt an approach to treatment that considers all available options

Professor Xavier Cos discusses why primary care physicians are so important in diabetes management.Learning objectives: Following this activity, you will be more confident in tailoring treatment and developing a plan for all patients in your clinic.

Professor Knop provides advice on using these agents in combination – who would benefit most, managing potential side effects and considerations for use.Learning objectives: Following this activity, you will be able to:  Confidently identify people who would benefit from this combination and better prepare people for what they might expect in glucose control, side effects and weight loss.